Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Argon Laser Treatment of von Hippel-Lindau Retinal Angiomas

Argon Laser Treatment of von Hippel-Lindau Retinal Angiomas Abstract Twelve angiomas in two patients with von Hippel-Lindau disease were photocoagulated with the argon laser. At the levels of energy employed, this instrument was capable of occluding small and medium-sized feeder arterioles, but not vessels of large caliber. The laser also appeared capable of obliterating small angiomas (<0.8 disc diameters) following direct photocoagulation of the angiomas themselves. Larger angiomas were not always as susceptible to argon treatment. Late recurrence was noted clinically in one patient. Direct coagulation of the angioma may preserve more visual field than interruption of feeder arterioles. Fluorescein angiography is often valuable in determining whether or not retreatment is indicated, but may occasionally indicate absence of perfusion in the presence of a viable tumor. References 1. Welch R: von Hippel-Lindau disease: The recognition and treatment of early angiomatosis retinae and the use of cryosurgery as an adjunct to therapy . Trans Ophthalmol Soc 68:367-424, 1970. 2. Meyer-Schwickerath G: Light Coagulation . SM Drance (trans), St. Louis, CV Mosby Co, 1960. 3. Sellors PJH, Archer D: The management of retinal angiomatosis . Trans Ophthalmol Soc UK 89:529-543, 1969. 4. Wessing A: Ten Jahre Lichtkoagulation bei Angiomatosis retinae . Klin Monatsbl Augenheilkd 150:57-71, 1967. 5. Apple DJ, Goldberg MF, Wyhinny GJ: Argon laser treatment of von Hippel-Lindau retinal angiomas: II. Histopathology of treated lesions . Arch Ophthalmol 92:126-130, 1974.Crossref 6. Goldberg MF: Treatment of proliferative sickle retinopathy . Trans Am Acad Ophthalmol Otolaryngol 75:532-556, 1971. 7. Goldberg MF, Acacio I: Argon laser photocoagulation of proliferative sickle retinopathy . Arch Ophthalmol 90:35-44, 1973.Crossref 8. Goldberg MF, Duke JR: von Hippel-Lindau disease. Histopathologic findings in a treated and an untreated eye . Am J Ophthalmol 66:693-705, 1968. 9. Fankhauser F, Lotmar W, Roulier A: Reduction of energy in photocoagulation with the Zeiss-Oberkochen xenon-arc apparatus: I. Development of a short-pulse, small spot technique on rabbit eyes . Albrecht von Graefes Arch Klin Ophthalmol 182:177-188, 1971.Crossref 10. Watzke RC: Cryotherapy for retinal angiomatosis: A clinical-pathologic report . Doc Ophthalmol 34:405-411, 1973.Crossref 11. Landers MB III: Fluorescein angiography: Case presentation . Ann Ophthalmol 5:436-442, 1973. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Ophthalmology American Medical Association

Argon Laser Treatment of von Hippel-Lindau Retinal Angiomas

Loading next page...
 
/lp/american-medical-association/argon-laser-treatment-of-von-hippel-lindau-retinal-angiomas-5Inp4gkRAV

References (13)

Publisher
American Medical Association
Copyright
Copyright © 1974 American Medical Association. All Rights Reserved.
ISSN
0003-9950
eISSN
1538-3687
DOI
10.1001/archopht.1974.01010010127009
Publisher site
See Article on Publisher Site

Abstract

Abstract Twelve angiomas in two patients with von Hippel-Lindau disease were photocoagulated with the argon laser. At the levels of energy employed, this instrument was capable of occluding small and medium-sized feeder arterioles, but not vessels of large caliber. The laser also appeared capable of obliterating small angiomas (<0.8 disc diameters) following direct photocoagulation of the angiomas themselves. Larger angiomas were not always as susceptible to argon treatment. Late recurrence was noted clinically in one patient. Direct coagulation of the angioma may preserve more visual field than interruption of feeder arterioles. Fluorescein angiography is often valuable in determining whether or not retreatment is indicated, but may occasionally indicate absence of perfusion in the presence of a viable tumor. References 1. Welch R: von Hippel-Lindau disease: The recognition and treatment of early angiomatosis retinae and the use of cryosurgery as an adjunct to therapy . Trans Ophthalmol Soc 68:367-424, 1970. 2. Meyer-Schwickerath G: Light Coagulation . SM Drance (trans), St. Louis, CV Mosby Co, 1960. 3. Sellors PJH, Archer D: The management of retinal angiomatosis . Trans Ophthalmol Soc UK 89:529-543, 1969. 4. Wessing A: Ten Jahre Lichtkoagulation bei Angiomatosis retinae . Klin Monatsbl Augenheilkd 150:57-71, 1967. 5. Apple DJ, Goldberg MF, Wyhinny GJ: Argon laser treatment of von Hippel-Lindau retinal angiomas: II. Histopathology of treated lesions . Arch Ophthalmol 92:126-130, 1974.Crossref 6. Goldberg MF: Treatment of proliferative sickle retinopathy . Trans Am Acad Ophthalmol Otolaryngol 75:532-556, 1971. 7. Goldberg MF, Acacio I: Argon laser photocoagulation of proliferative sickle retinopathy . Arch Ophthalmol 90:35-44, 1973.Crossref 8. Goldberg MF, Duke JR: von Hippel-Lindau disease. Histopathologic findings in a treated and an untreated eye . Am J Ophthalmol 66:693-705, 1968. 9. Fankhauser F, Lotmar W, Roulier A: Reduction of energy in photocoagulation with the Zeiss-Oberkochen xenon-arc apparatus: I. Development of a short-pulse, small spot technique on rabbit eyes . Albrecht von Graefes Arch Klin Ophthalmol 182:177-188, 1971.Crossref 10. Watzke RC: Cryotherapy for retinal angiomatosis: A clinical-pathologic report . Doc Ophthalmol 34:405-411, 1973.Crossref 11. Landers MB III: Fluorescein angiography: Case presentation . Ann Ophthalmol 5:436-442, 1973.

Journal

Archives of OphthalmologyAmerican Medical Association

Published: Aug 1, 1974

There are no references for this article.